Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fexofenadine vs Montelukast in Seasonal Allergic Rhinitis
NCT00637611Phase 4Completed
- Sponsor
- Sanofi
- Start
- Feb 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of fexofenadine in seasonal allergic rhinitis (SAR), sponsored by Sanofi. Started Feb 2003; status: completed.
02
Drugs
fexofenadine
03
Conditions
seasonal allergic rhinitis (SAR)
Beyond the preview
Go deeper on NCT00637611.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00637611.